Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Communicating anthrax in 2001: a comparison of CDC information and print media accounts.

Mebane F, Temin S, Parvanta CF.

J Health Commun. 2003;8 Suppl 1:50-82; discussion 148-51.

PMID:
14692572
2.

Uncertain science and certain deadlines: CDC responses to the media during the anthrax attacks of 2001.

Robinson SJ, Newstetter WC.

J Health Commun. 2003;8 Suppl 1:17-34; discussion 148-51.

PMID:
14692570
3.

Communicating health information to an alarmed public facing a threat such as a bioterrorist attack.

Hobbs J, Kittler A, Fox S, Middleton B, Bates DW.

J Health Commun. 2004 Jan-Feb;9(1):67-75.

PMID:
14761834
4.

Inhalational anthrax due to bioterrorism: would current Centers for Disease Control and Prevention guidelines have identified the 11 patients with inhalational anthrax from October through November 2001?

Mayer TA, Morrison A, Bersoff-Matcha S, Druckenbrod G, Murphy C, Howell J, Hanfling D, Cates R, Pauze D, Earls J.

Clin Infect Dis. 2003 May 15;36(10):1275-83. Epub 2003 May 9.

PMID:
12746773
5.

Update: Investigation of bioterrorism-related anthrax, 2001.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2001 Nov 16;50(45):1008-10.

6.

Call-tracking data and the public health response to bioterrorism-related anthrax.

Mott JA, Treadwell TA, Hennessy TW, Rosenberg PA, Wolfe MI, Brown CM, Butler JC.

Emerg Infect Dis. 2002 Oct;8(10):1088-92.

7.

Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax.

Tierney BC, Martin SW, Franzke LH, Marano N, Reissman DB, Louchart RD, Goff JA, Rosenstein NE, Sever JL, McNeil MM; Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program.

Clin Infect Dis. 2003 Oct 1;37(7):905-11. Epub 2003 Sep 12.

PMID:
13130401
8.

Exploring the presentation of news information about the HPV vaccine: a content analysis of a representative sample of U.S. newspaper articles.

Quintero Johnson J, Sionean C, Scott AM.

Health Commun. 2011 Sep;26(6):491-501. doi: 10.1080/10410236.2011.556080. Epub 2011 Jun 24.

PMID:
21469005
9.
10.

Communication monitoring: shaping CDC's emergency risk communication efforts.

Prue CE, Lackey C, Swenarski L, Gantt JM.

J Health Commun. 2003;8 Suppl 1:35-49; discussion 148-51.

PMID:
14692571
11.

Impact of the mass media on calls to the CDC National AIDS Hotline.

Fan DP.

Int J Biomed Comput. 1996 Jun;41(3):207-16.

PMID:
8872195
12.

Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.

Mason JO, Noble GR, Lindsey BK, Kolbe LJ, Van Ness P, Bowen GS, Drotman DP, Rosenberg ML.

Public Health Rep. 1988 May-Jun;103(3):255-60.

13.
14.

Bioterrorism-related anthrax: international response by the Centers for Disease Control and Prevention.

Polyak CS, Macy JT, Irizarry-De La Cruz M, Lai JE, McAuliffe JF, Popovic T, Pillai SP, Mintz ED; Emergency Operations Center International Team.

Emerg Infect Dis. 2002 Oct;8(10):1056-9.

15.

CDC has anthrax, smallpox vaccination guidelines available.

Traynor K.

Am J Health Syst Pharm. 2001 Nov 1;58(21):2008, 2011. No abstract available.

PMID:
11715817
16.

Did news reporters get it right? Translation of the 2002 hormone study findings.

Canales MK, Breslau ES, Nelson DE, Ballard-Barbash RR.

Am J Prev Med. 2008 Jan;34(1):61-8.

PMID:
18083452
17.
18.

Anthrax bioterrorism: lessons learned and future directions.

Hughes JM, Gerberding JL.

Emerg Infect Dis. 2002 Oct;8(10):1013-4. No abstract available.

19.
20.

CDC broadcast aims to improve clinicians' grasp of anthrax issues.

Traynor K.

Am J Health Syst Pharm. 2001 Dec 1;58(23):2212, 2216, 2218. No abstract available.

PMID:
11763795

Supplemental Content

Support Center